1[1]Yamamoto K,Mano T,Yoshida L,et al.ACE inhibitor and angiotensin Il type Ⅰ receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failuer[J].J Hypertens,2005,23(2):393-400
2[2]Node K,fujita M,Kitakaze M,et al.Short torm statin therapy improves cardiac function and sympotms in patients with idiopathic dilated crdiomyopatthy[J].Circulation,2003,108(7):839-843
3[3]Horwich TB,Maclellan WR,Fonarow GC,et al.Statin therapy is associated with improved survival in ischemic and non ischernic heart failure[J].J Am Coll Cordiol,2004,43(4):624-648
4[4]Hognestad A,Dickstein K,Myhre E,et al.Effect of combined statin and beta-blocker treatment on one-year mrodidity and mortality after acute myocardial infarction associated with heart failure[J].Am J Cardiol,2004,93(5):603-606
5[5]Lubien E,Denaria A,Kazanegre R,et al.Utiliy of B-tye natriuretic in detecting diastolic dysfunction:comparison with Dopple welocity recordings[J].Circulation,2002,105(3):595-601
7[7]Harjai KJ,Nunez E,Turgut T,et al.Effect of combined aspirin and angiotensin-converting enzyme inhibitor therapy versus alone on readmisson rates in heart failure[J].Am J Cardiol,2002,88 (4):483-487
8[8]Krumholz HM,Chen YT,Radford MJ,et al.Aspirin and the treatment of heart failuer in the elderly[J].Arch Intern Med,2002,162 (4):577-582
1Farre J, Romero J, Rubio JM, et al. Amiodarone and primary prevention of sudden death : critical review of a decade of clinical trials [J]. Am J Cardiol, 1999,83 : 55D- 63D.
2Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable cardioverter defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH)[J]. Circulation,2000,102:748-754.
3The antiarrhythmics versus implantable defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias [J].N Engl J Med, 1997, 337:1576 -1583.
4Mitchell LB, Pineda EA, Titus JL, et al. Sudden death in patients with implantable cardioventer defibrillators[J].J Am Coll Cardiol, 2002, 39:1323- 1328.
5Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone [J].Circulation,2000,101:1297-1302.
6Moss A J, Hall W J, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators[J]. N Engl J Med, 1996,335:1933-1940.
7Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden cardiac death in patients with coronary artery disease[J]. N Engl J Med, 1999, 341:1882- 1890.
8Moss AJ, Zareba W, Hall W J, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction[J]. N Engl J Med, 2002, 46:877-883.
9Bigger JT. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary artery bypass graft(CABG) patch trial investigators [J]. N Engl J Med, 1997,337:1569- 1575.
10Parkes J, Bryant J, Milne R. Implantable cardioverter defibrillators in arrhythrmas : a rapid and systematic review of effectiveness[J]. Heart, 2002, 87:438-442.
5CIBIS-Ⅱ Investigators and Committees.The Cardiac Insufficiency Bisoprolol StudyⅡ(CIBIS-Ⅱ):A randomized trial[J].Lancet,1999,353:2001-2006.
6Hjalmarson FG.Effects of controlled-release metoprolol on total mortality,hospitalization,and well-being in patients with hear failure,The Metoprolol CR/XLR and omized international Trial in Congestive Heart Failure(MERLT-HF)[J].JAMA,2000,283:295-302.
7Cesari M,Rossi GP,Pessina AC.Biological properties of the angiotensin peptides other than angiotentin Ⅱ:Implications for hypertension and cardiovascular diseases[J].J Hypertens,2002,20(5):799.
8Horiuchi M,Akishita M,Dzau VJ.Recent progress in angiotensin Ⅱtype receptor research in the cardiovascular system[J].Hypertension,1999,33(2):613-621.
9Levy BL.Can angiutensin Ⅱ type 2 receptors have deleterious effects in cardiovascular disease? Implication for therapeutic blockade of the renin-angiotentin system[J].Circulation,2004,109(1):8-13.
10Pfefer MA,Swedberg K,Granger CB,et al.CHARM Investigators and Comittees.Effects of candesartan onmortality and morbidity in patients with chronic heart failure:The CHARM -Overall programme.Cardesartan in heart failure:Assessment of readuction in morbidity and mortality(CHARM)[J].Lancet,2003,362:759-766.
